Japan's Nikkei opens 1 per cent higher. — Reuters pic
MSCI's broadest index of Asia-Pacific shares outside Japan rose 0.3 per cent to its highest since early January and sits just a fraction below a two-year high. The US Food and Drug Administration's move was hailed by President Donald Trump. Shares of AstraZeneca also rose on a Financial Times report that the US government was considering fast-tracking its experimental vaccine.
In currency markets, the US dollar, which has been sensitive to sentiment in equity markets edged higher, defying pressure from a gain in stocks that often leads investors to sell US dollars for riskier currencies.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: